Acyl Glucuronide of Oxidized Lenabasum (JBT‐101) as Human Major Metabolite: Identification, Large‐Scale Synthesis, and Activity Characterization-Reference-Cited by-同舟云学术

Acyl Glucuronide of Oxidized Lenabasum (JBT‐101) as Human Major Metabolite: Identification, Large‐Scale Synthesis, and Activity Characterization

Published:2021-11-10 Issue:42 Volume:6 Page:11753-11758
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Deng Hongfeng¹^ORCID,Leigh Clifton¹,Yang Yun²,Jin Zhuang¹,Sun Gang¹,Zhang Lipeng²,Feng Xiao¹,Moshos Kristos¹,White Barbara¹

Affiliation:

1. Corbus Pharmaceuticals Inc. Norwood MA 02062 United States

2. WuXi AppTec (Tianjin) Co., Ltd Tianjin 300457 P. R. China

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.202103050

Reference15 articles.

1. Corbus Pharmaceuticals Inc. “Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis (RESOLVE-1)” to be found under ClinicalTrials.gov Identifier: NCT03398837 2021.

2. Corbus Pharmaceuticals Inc. “Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis” to be found under ClinicalTrials.gov Identifier: NCT03451045 2021.

3. Corbus Pharmaceuticals Inc. “Trial and Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis (DETERMINE)” to be found under ClinicalTrials.gov Identifier: NCT03813160 2021.

4. Corbus Pharmaceuticals Inc. “JBT-101 in Systemic Lupus Erythematosis (SLE)” to be found under ClinicalTrials.gov Identifier: NCT03093402 2021.

5. Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acyl Glucuronide of Oxidized Lenabasum (JBT‐101) as Human Major Metabolite: Identification, Large‐Scale Synthesis, and Activity Characterization;ChemistrySelect;2021-11-10